Vahdat said which one area in which AI could be hugely beneficial in improving efficiency in addition to cutting costs was cardiological care.
“If we collect data in real time in addition to combine This particular with their historical data as well as data by millions of similar patients, an intelligent system could predict a heart attack having a high rate of precision,” he said.
“This particular will allow us to save countless lives in addition to save health care systems around the globe huge spend.”
however some experts fear the fast-paced nature of the still nascent AI industry could come at the risk of patient safety.
“We are concerned which within the rush to roll out AI in addition to push the boundaries of technology, there is actually a risk which important checks in addition to balances which have been established to keep patients safe might be seen as an afterthought, or be bypassed entirely,” Stokes-Lampard said.
Last month, a report by online health publication Stat said which IBM’s Watson supercomputer had made multiple “unsafe in addition to incorrect” cancer treatment recommendations, citing internal company documents. According to Stat, the program had only been trained to deal having a little number of cases in addition to hypothetical scenarios instead of actual patient data. IBM subsequently told CNBC which This particular has “learned in addition to increased Watson Health based on continuous feedback by clients, brand new scientific evidence in addition to brand new cancers in addition to treatment alternatives.”
Stokes-Lampard said which regulators should keep pace with the rapid advances in technology to avoid harm to patients.
She said: “In an ever-changing ‘tech space,’ This particular is actually imperative which regulation keeps up with all technological developments, in addition to which This particular is actually appropriately enforced, in order which patients are kept safe, however they choose to access care.”
however many tech companies — big in addition to little — are mostly averse to brand new regulation, arguing This particular could restrain innovation.
“There are a lot of regulations to protect patients already,” Medopad’s Vahdat said. “This particular isn’t about adding more regulation — This particular is actually about adapting in addition to applying existing regulations to better deal with current realities.”
He added: “Patients as a cohort are often vulnerable in addition to we feel responsible to not create trust which is actually not qualified. We feel strongly which unless our technology is actually clinically validated This particular shouldn’t be marketed. Like doctors, health care start-ups should seek to fully understand the ethical implications of creating expectations with patients.”